A Look At CNO Financial Group (CNO) Valuation As Recent Share Momentum Slows

Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge.

CNO Financial Group (CNO) has been drawing attention after recent share performance, with the stock showing declines over the past month and the past three months, while longer term returns remain positive.

See our latest analysis for CNO Financial Group.

At a share price of $39.74, CNO’s recent 30 day and 90 day share price returns of around 8% sit in contrast to its 3 year total shareholder return of about 100%, suggesting momentum has cooled following a strong multi year run.

If this insurance name has you reassessing where growth and income could come from next, it may be worth broadening your watchlist with 20 top founder-led companies

With CNO trading at $39.74 and sitting at a discount to some analyst targets and an estimated intrinsic value, the key question is whether the recent pullback leaves room for upside or if the market is already pricing in future growth.

With CNO Financial Group’s shares at $39.74 versus a narrative fair value of $48, the current gap centers on how future earnings power and margins are expected to evolve using a 7.75% discount rate.

Analysts are assuming CNO Financial Group’s revenue will decrease by 1.2% annually over the next 3 years.

Read the complete narrative.

Revenue is not the hero of this story. The valuation leans on a profit profile shift, expanding margins and a different earnings multiple by 2029.

Result: Fair Value of $48 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, investors still need to weigh interest rate pressure on investment income, as well as any setback in CNO’s digital push that could keep acquisition costs higher for longer.

Find out about the key risks to this CNO Financial Group narrative.

There is a clear gap between the narrative fair value of $48 and where CNO trades today, but the picture shifts when looking at relative pricing. CNO’s P/E of 16.3x sits above the US Insurance industry and peer average of 10.8x, and slightly above a fair ratio of 16x, which points to less room for error if earnings or sentiment disappoint.

See what the numbers say about this price — find out in our valuation breakdown.

If this mix of optimism and caution reflects how you are feeling, now is a good time to look closely at both sides of the story and weigh 4 key rewards and 4 important warning signs

If CNO has you rethinking your next move, do not stop here. Broaden your opportunity set with focused stock ideas filtered by quality, value, and income.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include CNO.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com